CWM
XENE icon

CIBC World Markets’s Xenon Pharmaceuticals XENE Stock Holding History

CIBC World Markets’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$225K Buy
+5,027
New +$211K ﹤0.01% 1066
2025
Q2 		$293K Buy
+9,363
New +$305K ﹤0.01% 1109

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

CIBC World Markets's XENE Position: Q4 2025 in Review

CIBC World Markets opened a new position in Xenon Pharmaceuticals (XENE) in Q4 2025: 5,027 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #1066 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in XENE as recently as Q2 2025.

CIBC World Markets first reported a position in XENE in Q2 2025 and has held it in 2 quarters since. The position peaked at $293K in Q2 2025. 245 funds tracked by Wall St. Rank hold XENE as of Q4 2025.

  • CIBC World Markets held 5,027 shares of Xenon Pharmaceuticals worth $225K as of Q4 2025.
  • Xenon Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Xenon Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1066 holding.
  • CIBC World Markets first reported a position in Xenon Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Xenon Pharmaceuticals position peaked at $293K in Q2 2025.
  • 245 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.